Medical product reviewers were spared during the layoffs at FDA, but cuts to support and policy staff likely will slow drug and device development and approval, hurting American patients. #healthpolicy #biosky #medsky insights.citeline.com/pink-sheet/a... - ThreadSky | a Reddit-style client for Bluesky

sarahkarlin-smith.bsky.social • 6 days ago

Medical product reviewers were spared during the layoffs at FDA, but cuts to support and policy staff likely will slow drug and device development and approval, hurting American patients. #healthpolicy #biosky #medsky

https://insights.citeline.com/pink-sheet/agency-leadership/us-fda/fda-layoffs-us-likely-to-lose-its-first-approver-advantage-5C37YQ73DNBEFF7SHRYV4MJUIA/

Comments